Merck Buys OncoImmune in COVID Treatment Move
The $425 million deal gives Merck access to a promising therapy for treating seriously ill COVID-19 patients.
Merck Enters Race to Develop COVID Vaccine
The world's largest vaccine maker is no longer on the COVID sidelines after acquiring an Austrian biotech and teaming up with a nonprofit.
Merck, Sanofi in Deals for Cancer Drug Firms
The pharma giants each announced they would buy smaller drugmakers to expand cancer-treatment franchises.
Merck Goes Hostile in Versum Takeover Battle
Versum shareholders are scheduled to vote next month on a merger with Entegris that is valued at less than Merck's $5.9 billion proposal.
Bayer to Shed Assets, Cut Jobs Amid Share Pressure
It's a broad restructuring of the German conglomerate, which plans to sell its sun-care and foot care businesses and exit its animal health division.
P&G Buys Merck Unit to Boost OTC Business
The $4 billion acquisition of Merck's consumer healthcare unit comes amid investor pressure on P&G to increase sales.
Data Held Hostage
The damage inflicted in this year’s ransomware attacks will force corporations to review their IT resilience.
Quantifying Cyber Risks
Companies are clamoring for the data and information they need to manage their exposures.
Merck Buys Cough Drug Developer for $1.25B
The acquisition of Afferent Pharmaceuticals gives Merck access to a drug candidate for treating neurogenic conditions including chronic cough.
Ex-Merck Analyst Hit with Insider Trading Rap
He allegedly helped a friend make more than $700,000 on insider M&A info.